Anida Pharma is a biopharmaceutical company developing therapies to treat Amyotropic Lateral Sclerosis, Parkinsons Disease, other CNS disorders and hearing loss.
ANIDA Pharma Inc.
In 2013, it has entered a research partnership with ALS Therapy Development Institute (ALS TDI) for investigating a potential treatment for ALS. Under the terms of agreement ALS TDI will be testing its lead compound for its functional benefit.[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”” connections=”true” suffix=””]
In Sep 2013, Anida Pharma, has been awarded funding by The Michael J. Fox Foundation for Parkinsons Research (MJFF) to conduct pre-clinical research using its lead compound Neuroprotectin D1, for treatment of neurodegenerative diseases.